NCT01838499: Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa |
|
|
| Terminated | 2a | 224 | US | MEDI8968, Investigational Product, Saline, Placebo | AstraZeneca, ICON plc, Covance, PHT Corporation | Hidradenitis Suppurativa | 10/14 | 10/14 | | |
